Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
Understanding the role of lifetime ovulatory years and DNA repair variants on ovarian cancer risk in the United Kingdom Biobank.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Garofalo Diana C, Cleary Cristian R, Ottman Ruth, Terry Mary Beth, Genkinger Jeanine M
Аннотация
BACKGROUND: Epithelial ovarian cancer (EOC) risk factors span protective exposures such as parity and contraceptive use, and risk-elevating traits including early menarche and late menopause. Together, these factors dictate lifetime ovulatory years (LOY), which may drive carcinogenesis via an ovulation-induced, DNA-damage promoting microenvironment.
METHODS: This study tested the theory that DNA repair capacity and LOY are synergistic partners by evaluating gene-environment interaction between DNA repair capacity (the presence of pathogenic variants in DNA repair genes in 251,476 at-risk females in the United Kingdom (UK) Biobank, including 847 incident EOC cases) and LOY, using a novel DNA repair capacity score.
RESULTS: We confirmed the association between increasing LOYs and EOC risk in the UK Biobank (hazard ratio [HR]: 1.15 [1.10, 1.20] per 5-year increase in LOY). We also observed strong associations between pathogenic DNA repair variants and ovarian cancer; individuals with at least one variant in 163 DNA repair genes evaluated had a significantly increased hazard of EOC (HR: 1.27, 95% CI: 1.05, 1.55). Participants with both high LOY and at least one variant had an HR of 2.00 (1.54, 2.59), however we did not observe gene-LOY interaction.
CONCLUSIONS: We detected evidence that increasing LOYs and pathogenic DNA repair variants are independent risk factors of EOC, with no evidence of synergy in this population.
IMPACT: In the UK Biobank, greater lifetime ovulations were associated with ovarian cancer risk. Rare pathogenic DNA repair variants also conferred high risk, independent of ovulatory years.
METHODS: This study tested the theory that DNA repair capacity and LOY are synergistic partners by evaluating gene-environment interaction between DNA repair capacity (the presence of pathogenic variants in DNA repair genes in 251,476 at-risk females in the United Kingdom (UK) Biobank, including 847 incident EOC cases) and LOY, using a novel DNA repair capacity score.
RESULTS: We confirmed the association between increasing LOYs and EOC risk in the UK Biobank (hazard ratio [HR]: 1.15 [1.10, 1.20] per 5-year increase in LOY). We also observed strong associations between pathogenic DNA repair variants and ovarian cancer; individuals with at least one variant in 163 DNA repair genes evaluated had a significantly increased hazard of EOC (HR: 1.27, 95% CI: 1.05, 1.55). Participants with both high LOY and at least one variant had an HR of 2.00 (1.54, 2.59), however we did not observe gene-LOY interaction.
CONCLUSIONS: We detected evidence that increasing LOYs and pathogenic DNA repair variants are independent risk factors of EOC, with no evidence of synergy in this population.
IMPACT: In the UK Biobank, greater lifetime ovulations were associated with ovarian cancer risk. Rare pathogenic DNA repair variants also conferred high risk, independent of ovulatory years.